GM vs TERN · P/E 7.5, rev $185.02B vs $6.12B cap
General Motors Company (GM) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
General Motors Company (GM) is a auto manufacturers company listed on US. It is led by Mary Barra.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported GM revenue for 2025-12-31 was $185.02B. Net income was $2.70B. Revenue was down 1.3% from 2024-12-31 to 2025-12-31. GM currently screens at market cap $51.33B and trailing P/E 7.5.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
GM currently screens at market cap $51.33B and trailing P/E 7.5. TERN currently screens at market cap $6.12B.
Not investment advice. Open the GM and TERN stock pages for the full models.
Not investment advice.